Ignite Creation Date:
2025-12-25 @ 5:05 AM
Ignite Modification Date:
2026-03-06 @ 6:23 PM
Study NCT ID:
NCT00436527
Status:
COMPLETED
Last Update Posted:
2022-07-29
First Post:
2007-02-16
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Assess the Ability of MetroGel 1% to Deliver Moisture to Facial Skin After a Single Application
Sponsor:
Galderma R&D
Organization:
Study Overview
Official Title:
MetroGel 1% Hydration Study: A Kinetic Regression Study
Status:
COMPLETED
Status Verified Date:
2008-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This eight-hour kinetic regression clinical study was conducted to assess the ability of MetroGel® 1% to deliver moisture to facial skin after a single application.
Detailed Description:
This eight-hour kinetic regression clinical study was conducted to assess the ability of MetroGel® 1% to deliver moisture to facial skin after a single application as measured by the Corneometer CM 825.
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: